Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology
Daxor Corporation (DXR) has expanded its presence in Florida by launching a new Blood Volume Analysis (BVA) program at a major healthcare center in Tampa Bay. The facility will utilize Daxor's Tennessee-based CLIA-certified ezBVA Lab service, which provides blood volume analysis results within 24 hours of sample receipt.
The service offers 98% accurate measurements for fluid management in various conditions including cardiac, renal, and critical care. The ezBVA Lab service eliminates the need for capital investment while maintaining full reimbursement through CPT codes under both public and private insurance plans.
Daxor Corporation (DXR) ha ampliato la sua presenza in Florida lanciando un nuovo programma di Analisi del Volume Sanguigno (BVA) presso un importante centro sanitario nella zona di Tampa Bay. La struttura utilizzerà il servizio ezBVA Lab di Daxor, certificato CLIA e con sede in Tennessee, che fornisce risultati dell'analisi del volume sanguigno entro 24 ore dalla ricezione del campione.
Il servizio offre misurazioni con accuratezza del 98% per la gestione dei fluidi in diverse condizioni, tra cui cardiache, renali e di terapia intensiva. Il servizio ezBVA Lab elimina la necessità di investimenti in capitale, garantendo al contempo il rimborso completo tramite codici CPT sia per assicurazioni pubbliche che private.
Daxor Corporation (DXR) ha ampliado su presencia en Florida lanzando un nuevo programa de Análisis de Volumen Sanguíneo (BVA) en un importante centro de salud en Tampa Bay. La instalación utilizará el servicio ezBVA Lab de Daxor, certificado CLIA y con sede en Tennessee, que proporciona resultados de análisis de volumen sanguíneo dentro de las 24 horas posteriores a la recepción de la muestra.
El servicio ofrece mediciones con una precisión del 98% para la gestión de líquidos en diversas condiciones, incluyendo cardíacas, renales y cuidados críticos. El servicio ezBVA Lab elimina la necesidad de inversiones de capital mientras mantiene el reembolso completo a través de códigos CPT tanto en planes de seguros públicos como privados.
Daxor Corporation (DXR)는 플로리다에서 입지를 확대하여 탬파 베이의 주요 의료 센터에서 새로운 혈액량 분석(BVA) 프로그램을 시작했습니다. 이 시설은 테네시에 위치한 CLIA 인증 ezBVA Lab 서비스를 이용하며, 샘플 수령 후 24시간 이내에 혈액량 분석 결과를 제공합니다.
이 서비스는 심장, 신장 및 중환자 치료를 포함한 다양한 상태에서 체액 관리에 대해 98% 정확한 측정을 제공합니다. ezBVA Lab 서비스는 자본 투자 없이도 CPT 코드를 통한 공공 및 민간 보험 모두에서 전액 환급을 보장합니다.
Daxor Corporation (DXR) a renforcé sa présence en Floride en lançant un nouveau programme d'analyse du volume sanguin (BVA) dans un centre de santé majeur de Tampa Bay. L'établissement utilisera le service ezBVA Lab de Daxor, certifié CLIA et basé dans le Tennessee, qui fournit les résultats d'analyse du volume sanguin sous 24 heures après réception de l'échantillon.
Le service offre des mesures avec une précision de 98% pour la gestion des fluides dans diverses conditions, notamment cardiaques, rénales et en soins intensifs. Le service ezBVA Lab supprime le besoin d'investissement en capital tout en maintenant un remboursement complet via les codes CPT, tant pour les assurances publiques que privées.
Daxor Corporation (DXR) hat seine Präsenz in Florida erweitert und ein neues Blutvolumenanalyse-Programm (BVA) in einem großen Gesundheitszentrum in Tampa Bay gestartet. Die Einrichtung nutzt den CLIA-zertifizierten ezBVA Lab-Service von Daxor mit Sitz in Tennessee, der Blutvolumenanalyse-Ergebnisse innerhalb von 24 Stunden nach Probeneingang liefert.
Der Service bietet 98% genaue Messungen für das Flüssigkeitsmanagement bei verschiedenen Erkrankungen, einschließlich Herz-, Nieren- und Intensivpflege. Der ezBVA Lab-Service erfordert keine Kapitalinvestitionen und gewährleistet gleichzeitig vollständige Erstattung über CPT-Codes bei öffentlichen und privaten Versicherungen.
- Integration of BVA testing across both inpatient and outpatient care programs
- 98% accuracy in blood volume measurements
- 24-hour turnaround time for test results
- No capital investment required for healthcare facilities
- Full reimbursement available through established CPT codes
- None.
Daxor's ezBVA Lab Service Marks New Standard in Precision Fluid Management
Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor's innovative blood volume analysis (BVA) testing across the facility's inpatient and outpatient care programs, revolutionizing fluid management precision and enhancing treatment outcomes for a spectrum of conditions.
The facility will utilize Daxor's state-of-the-art Tennessee-based CLIA-certified ezBVA Lab that delivers comprehensive blood volume analysis results within 24 hours of sample receipt.
“This exciting hallmark marks another significant milestone in our ongoing Florida expansion and underscores the critical role of precise volume assessment in patient care,” said Michael Feldschuh, Daxor's CEO and President. “Our diagnostic technology provides clinicians with
About Daxor Corporation
Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at leading hospital centers across the U.S., enhancing hospital performance metrics in a broad range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. Daxor has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the U.S. Department of Defense. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all. For more information, please visit our website at Daxor.com. Sign up to receive news on Daxor’s innovative technology HERE.
Forward-Looking Statements
Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
Bret Shapiro
Sr. Managing Partner, CORE IR
1-516-222-2560
brets@coreir.com
FAQ
What is the accuracy rate of Daxor's (DXR) blood volume analysis technology?
How long does it take to get results from Daxor's ezBVA Lab service?
What medical conditions can Daxor's (DXR) BVA technology be used for?
Is Daxor's ezBVA Lab service covered by insurance?
